MOINUDDIN KAZI

Allopathic & Osteopathic Physicians|Family Medicine DUNWOODY, GA NPI 1487746483

General Payments — all program years on this page

$470.03

  • Category: General Payments
  • Program years: PY2018–2019
  • Record count: 29
  • As of (CMS publication): 2026-01-23

Latest program year (PY2019): $265.55 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2019) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $265.5516

By paying entity

Latest program year (PY2019) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $110.956
Gilead Sciences, Inc. $46.393
NOVARTIS PHARMACEUTICALS CORPORATION $36.982
PFIZER INC. $30.172
Lilly USA, LLC $26.312
Astellas Pharma US Inc $14.751

By program year

Program yearAmountRecords
2018 $204.4813
2019 $265.5516

Records — PY2019 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
655631149 Astellas Pharma US Inc $14.75 05/22/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
658054617 Lilly USA, LLC $15.39 05/01/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
658054619 Lilly USA, LLC $10.92 06/26/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
659666481 Novartis Pharmaceuticals Corporation $16.74 11/06/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
659666483 Novartis Pharmaceuticals Corporation $20.24 12/04/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
672031203 PFIZER INC. $18.49 06/12/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
672636055 PFIZER INC. $11.68 08/21/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
681540667 Gilead Sciences, Inc. $17.14 02/06/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
681540669 Gilead Sciences, Inc. $14.28 04/30/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
681540671 Gilead Sciences, Inc. $14.97 10/17/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685093843 AstraZeneca Pharmaceuticals LP $17.60 06/25/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685127779 AstraZeneca Pharmaceuticals LP $18.85 09/18/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685247017 AstraZeneca Pharmaceuticals LP $16.85 11/21/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685312573 AstraZeneca Pharmaceuticals LP $18.89 10/30/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685314755 AstraZeneca Pharmaceuticals LP $20.19 08/28/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685723719 AstraZeneca Pharmaceuticals LP $18.57 06/06/2019 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.